United Therapeutics Corporation (UTHR)
$493.99
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Key data on UTHR
Market cap
$21.27B
EPS
26.43
P/E ratio
18.6
Price to sales
6.8
Dividend yield
--
Beta
0.861238
Price on UTHR
Previous close
$488.51
Today's open
$491
Day's range
$488.75 - $496.73
52 week range
$266.98 - $496.73
Profile about UTHR
show more
CEO
Martine Rothblatt
Employees
1305
Headquarters
Silver Spring, MD
Exchange
Nasdaq Global Select
Shares outstanding
43056599
Issue type
Common Stock
Popular stocks like UTHR
UTHR industries and sectors
Healthcare
Biotechnology & Life Sciences
News on UTHR
Here's Why United Therapeutics (UTHR) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Dec 11, 2025
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Dec 10, 2025
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Dec 9, 2025
Flurry of Bullish Inflows Sends United Therapeutics Higher
United Therapeutics Corporation (UTHR) shares up 3,603% since Big Money first bought big in 2004.
FXEmpire • Dec 3, 2025
United Therapeutics Stock, Up 72% Since August, Nears Buy Point Of Rare Base
The Big Cap 20 pick to watch is United Therapeutics stock, which is up 72% in the last few months.
Investors Business Daily • Nov 21, 2025
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 20, 2025
United Therapeutics Corporation (UTHR) Presents at Jefferies London Healthcare Conference 2025 Transcript
United Therapeutics Corporation ( UTHR ) Jefferies London Healthcare Conference 2025 November 18, 2025 7:00 AM EST Company Participants Harrison Silvers - Manager of Investor Relations James Edgemond - CFO & Treasurer Conference Call Participants Jiale Song - Jefferies LLC, Research Division Presentation Jiale Song Jefferies LLC, Research Division Welcome, everyone, to Jefferies London Healthcare Conference 2025. My name is Roger Song, one of the senior analysts cover SMid-cap biotech in the U.S. It is my pleasure to have the fireside chat with our next company, United Therapeutics, James and Harry.
Seeking Alpha • Nov 18, 2025
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 12, 2025
United Therapeutics Corporation (UTHR) Presents at UBS Global Healthcare Conference 2025 Transcript
United Therapeutics Corporation ( UTHR ) UBS Global Healthcare Conference 2025 November 10, 2025 9:30 AM EST Company Participants Patrick Poisson - Executive VP of Technical Operations Conference Call Participants Ashwani Verma - UBS Investment Bank, Research Division Terence Flynn - Morgan Stanley, Research Division Presentation Ashwani Verma UBS Investment Bank, Research Division Good day, everybody. Welcome to UBS Healthcare Conference.
Seeking Alpha • Nov 10, 2025
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • Nov 5, 2025
¹ Disclosures
Invest in United Therapeutics Corporation
Open an M1 investment account to buy and sell United Therapeutics Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.